Transactions UK

Law360 UK Transactions delivers daily news, real-time alerts and forward-thinking analysis on corporate transactions trends and deals in the U.K. and EU including hostile takeovers, friendly mergers, IPOs, buyouts and shareholder disputes – and the laws and regulation surrounding them.

This essential newswire is a daily must-read for successful transactions lawyers to keep up with the latest deals and dealmakers, make informed business decisions and capitalize on opportunities as they unfold.



Sign up for a 7-day FREE trial today!



Latest News in Transactions UK

  • July 15, 2024

    Biotech Firm Destiny To Delist From AIM

    Destiny Pharma PLC on Monday proposed quitting London's alternative investment market to go private, saying doing so gives it a better chance of raising funds for developing its key drug program than as a public business.

  • July 15, 2024

    Labour Gov't Urged To Consult On Green Finance Rules

    A trade body for financial institutions has urged the Labour government to consult before imposing extra rules on firms' plans to transition to the green economy to avoid liability risks.

  • July 15, 2024

    Tips For Implementing EU Sustainability Reporting Guidance

    Lawyers at Sullivan & Cromwell discuss the European Financial Reporting Advisory Group’s recently published guidance on double materiality assessments and offer takeaways on achieving a sustainability directive-compliant process that could enhance clarity and consistency among multinational stakeholders.

  • July 15, 2024

    Cosmetics Packager Texen To Buy Rival In €140M Deal

    French luxury beauty packager Texen SAS plans to merge with Quadpack Industries SA in a take-private deal that values the Spanish rival at €140 million ($153 million), the companies said on Monday.

  • July 15, 2024

    AstraZeneca Completes $1B Amolyt Pharma Takeover

    AstraZeneca said Monday that it has successfully completed the approximately $1.05 billion acquisition of clinical stage biotechnology company Amolyt Pharma, which was guided by Freshfields, Jones Day and Cooley LLP, weeks after completing another $2.4 billion acquisition. 

See more Transactions UK news

Intellectual Property

Areas of Coverage

  • MERGERS, ACQUISITIONS & DISPOSALS:
  • Share swaps & cash acquisitions
  • IPOs, Cash Calls and Buybacks
  • Management buy-outs and buy-ins
  • Leveraged-buyouts
  • Shareholder agreements & Poison Pills
  • Activist shareholders and proxy fights
  • Venture capital and private equity deals
  • Distressed M&A: insolvency, restructuring, bailouts
  • AGENCIES
  • The Competition and Markets Authority
  • The Financial Conduct Authority
  • The Pension Regulator
  • POLICY & REGULATION
  • U.K. Takeover Code under the Companies Act
  • Financial Services and Markets Act
  • Market Abuse Regulation
  • The Enterprise Act

Readership

  • M&A lawyers
  • Commercial disputes lawyers at top law firms
  • Executives and attorneys at insurance companies and corporate policyholders
  • Corporate counsel and compliance officers at Fortune 1000 and FTSE 350 companies
  • Information experts at law firms, agencies and companies
  • Judges and court staff across the U.K.
  • Attorney and law firm marketing professionals
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!